Literature DB >> 22645354

Fibrogenic cell reversion underlies fibrosis regression in liver.

Scott Laurence Friedman1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22645354      PMCID： PMC3386124          DOI： 10.1073/pnas.1206645109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

1.  Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

Authors:  T Poynard; V Ratziu; F Charlotte; Z Goodman; J McHutchison; J Albrecht
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

Review 2.  Mechanisms of hepatic fibrogenesis.

Authors:  Scott L Friedman
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

3.  Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.

Authors:  Frank R Murphy; Razao Issa; Xiaoying Zhou; Shabna Ratnarajah; Hideaki Nagase; Michael J P Arthur; Christopher Benyon; John P Iredale
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

4.  Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.

Authors:  P Hammel; A Couvelard; D O'Toole; A Ratouis; A Sauvanet; J F Fléjou; C Degott; J Belghiti; P Bernades; D Valla; P Ruszniewski; P Lévy
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

Review 5.  History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells.

Authors:  A Geerts
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

6.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

Authors:  J P Iredale; R C Benyon; J Pickering; M McCullen; M Northrop; S Pawley; C Hovell; M J Arthur
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

7.  Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C.

Authors:  Vincent Mallet; Hélène Gilgenkrantz; Jeanne Serpaggi; Virginie Verkarre; Anaïs Vallet-Pichard; Hélène Fontaine; Stanislas Pol
Journal:  Ann Intern Med       Date:  2008-09-16       Impact factor: 25.391

8.  Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis.

Authors:  Penelope C Georges; Jia-Ji Hui; Zoltan Gombos; Margaret E McCormick; Andrew Y Wang; Masayuki Uemura; Rosemarie Mick; Paul A Janmey; Emma E Furth; Rebecca G Wells
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-11       Impact factor: 4.052

Review 9.  Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

Authors:  John P Iredale
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

10.  MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

Authors:  Jelena Mann; David C K Chu; Aidan Maxwell; Fiona Oakley; Nian-Ling Zhu; Hidekazu Tsukamoto; Derek A Mann
Journal:  Gastroenterology       Date:  2009-10-17       Impact factor: 22.682
View more
  17 in total

Review 1.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

2.  Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.

Authors:  Yong Zhou; Xiangwei Huang; Louise Hecker; Deepali Kurundkar; Ashish Kurundkar; Hui Liu; Tong-Huan Jin; Leena Desai; Karen Bernard; Victor J Thannickal
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

Review 3.  Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis.

Authors:  Christina E Barkauskas; Paul W Noble
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

Review 4.  Human hepatic stellate cell isolation and characterization.

Authors:  Linshan Shang; Mojgan Hosseini; Xiao Liu; Tatiana Kisseleva; David Allen Brenner
Journal:  J Gastroenterol       Date:  2017-11-01       Impact factor: 7.527

5.  Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.

Authors:  José Luis Casado; María Angeles Esteban; Sara Bañón; Ana Moreno; María J Perez-Elías; María Luisa Mateos; Santiago Moreno; Carmen Quereda
Journal:  Dig Dis Sci       Date:  2015-06-26       Impact factor: 3.199

Review 6.  Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings.

Authors:  Concetta Panebianco; Jude A Oben; Manlio Vinciguerra; Valerio Pazienza
Journal:  Clin Exp Med       Date:  2016-09-21       Impact factor: 3.984

Review 7.  Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?

Authors:  Youngmin A Lee; Scott L Friedman
Journal:  Antiviral Res       Date:  2014-04-12       Impact factor: 5.970

Review 8.  Hepatic inflammation and progressive liver fibrosis in chronic liver disease.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 9.  Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.

Authors:  Boris Hinz; David Lagares
Journal:  Nat Rev Rheumatol       Date:  2019-12-02       Impact factor: 20.543

10.  Syncoilin is an intermediate filament protein in activated hepatic stellate cells.

Authors:  E Van Rossen; Z Liu; D Blijweert; N Eysackers; I Mannaerts; B Schroyen; A El Taghdouini; B Edwards; K E Davies; E Sokal; M Najimi; H Reynaert; L A van Grunsven
Journal:  Histochem Cell Biol       Date:  2013-09-17       Impact factor: 4.304
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.